indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

Apollo Hospitals registers consolidated revenue of Rs 5,527 Cr in Q3 FY25

IMT News Desk

Posts Healthcare Services (HCS) revenue at Rs 2,785 crore

Apollo Hospitals has recently posted its Q3FY25 consolidated results.

REVENUE

Q3 FY25 revenues grew to Rs 5,527 crores; 14 per cent YoY growth

· Healthcare Services (HCS) revenue at Rs 2,785 crore; 13 per cent YoY growth

· AHLL: Revenues at Rs 390 crores; 15 per cent YoY growth

· Apollo HealthCo: Pharmacy Distribution & Digital Health Revenues at Rs 2,352 crores; 15 per cent YoY growth

· GMV of Apollo 24/7 at Rs 760 crores

EBITDA

Q3 FY25 consolidated EBITDA stood at Rs 762 Crores; 24 per cent YoY growth

· Healthcare Services (HCS) EBITDA at Rs 671 Crores; YoY growth of 14 per cent

· AHLL EBITDA at Rs 34 crores; YoY growth of 32 per cent

· Apollo HealthCo: Pharmacy distribution & Digital health EBITDA at Rs 57 crores

PAT

Q3 FY25 Consolidated PAT Rs 372 crores, compared to Rs 245 crores in Q3 FY24; 52 per cent YoY growth

· Healthcare Services (HCS) PAT at Rs 348 Crore; YoY growth of 21 per cent

Healthcare Services (Hospitals)

On December 31, 2024, Apollo Hospitals had 7,996 operating beds across the network (excluding AHLL & managed beds). The overall occupancy for hospitals was 68 per cent vs 66 per cent in the same period in the previous year, aided by a strong increase in patient flows across hospitals.

Consolidated Revenues of the healthcare services division increased by 13 per cent to Rs 2785 crore in Q3 FY25 compared to Rs 2463 crore in Q3 FY24.

EBITDA (Post Ind AS 116) was at Rs 670 crore in Q3 FY25 compared to Rs 586 crore in Q3 FY24. EBITDA was higher by 14 per cent YoY.

Revenues in the Tamil Nadu cluster grew by 8 per cent. ARPOB grew by 11 per cent to Rs 77,084. Overall occupancy in the cluster was 1,305 beds (64 per cent occupancy) as compared to 1,341 beds (66 per cent occupancy) in the previous year.

In AP, Telangana region, revenues grew by 24 per cent, IP volumes grew by 15 per cent. ARPOB grew by 9 per cent to Rs 63,013. Occupancy in the cluster was 815 beds (66 per cent occupancy) as compared to 718 beds (57% occupancy) in the previous year.

In the Karnataka region, revenues grew by 17 per cent, IP volumes grew by 5 per cent. ARPOB grew by 6 per cent to Rs 65,513. Occupancy in the cluster was 549 beds (71 per cent occupancy) as compared to 501 beds (67 per cent occupancy) in the previous year.

In the Eastern region, revenues grew by 8per cent, IP volumes grew by 5 per cent. ARPOB grew by 6 per cent to Rs 46,485. Occupancy in the cluster was 1,349 beds (72 per cent occupancy) as compared to 1,321 beds (73 per cent occupancy) in the previous year.

In the Western region, revenues grew by 12 per cent, IP volumes degrew by 2 per cent. ARPOB grew by 9 per cent to Rs 51,325. Occupancy in the cluster was 499 beds (57 per cent occupancy) as compared to 487 beds (57 per cent occupancy) in the previous year.

In the Northern region, revenues grew by 11 per cent, IP volumes grew by 10 per cent. ARPOB grew by 4 per cent to Rs 60,219. Occupancy in the cluster was 885 beds (74 per cent occupancy) as compared to 833 beds (70 per cent occupancy) in the previous year.

Dr Prathap C Reddy, Chairman, Apollo Hospitals Enterprise said, “With Q3 FY25 revenues rising by 14 per cent to Rs 5,527 crores and EBITDA by 24 per cent to Rs 762 crores, our performance is a testament to our commitment to a healthier India by bringing cutting-edge technologies to everyone who needs it. We are on track to add 3,512 beds across 11 locations over 3 to 4 years beginning FY26. The results reflect our growth story that underlines our purpose of healing India and touching more than a billion lives."

Recommended

Dr Nilesh G Satbhai joins Nanavati Max as Director of Plastic, Reconstructive Microsurgery & Hand Transplantation

OneSource Pharma registers Rs 3,758 M revenue in Q2FY26

Biocon posts Rs 4,296 Cr revenue at Q2FY26

NHA renews MoU with DHR and ICMR

Granules Life Sciences receives US FDA approval for Hyderabad facility

Cipla, Natco, Hetero and Annora Win Key Generic Drug Supply Contracts in China

Dementia India Alliance and Apollo AyurVAID Hospitals sign MoU

Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra in India

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions